InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Lingnau Lutz. Director active across 1 company, notably NEKTAR THERAPEUTICS. Aggregated, 2 filings have been published. Breakdown: 0 buy · 1 sell. Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations